“showed a trend”

Patients with FGFR1 alterations showed a trend toward lower PSA 50 rates that did not reach statistical significance (20% vs 51%, OR 0.24, 95% CI 0.05-1.18, P = .10).

After correction for the effect of age (Table 6 ) and tumor length (Table 6 ) the prognostic effect of inoperable patient on toxicity showed a trend for significance (p<. 10) and the odds ratio was high (>2.4) in all four corrected analyses.

The MENO group showed a trend towards a higher frequency of subjective memory complaints compared to PRE women and men (p ≤ .10).

In addition to experiencing significantly higher amounts stolen, older Black victims showed a trend ( p < .1) toward being more likely to experience out-of-pocket costs (OR = 1.86, 95% CI = 0.90–2.84, p = .09).

Only explanatory and confounding variables that showed a trend toward an association (eg, P < .10) with the outcome of interest in the univariate analysis were included in the multiple regression analysis.

Lambs fed the SOY diet showed a trend for diet × time interaction ( p < 0.1), pointing to higher concentrations of propionic acid at the expense of acetic acid at d 20.

Cytokines Gene Expression in Tissues Piglets from LSB-fed sows showed a trend toward a higher expression of IL-1α ( p < 0.1) in the lymph node compared to piglets from CON sows.

In contrast, macrophages polarized toward M2 showed a trend toward increased miR-494-3p expression compared with M0 (p = 0.1; Figure 1 A).

MRD response after C2 showed a trend for longer mOS (NR vs. 19m, p=0.1; Figure 2A) and LFS (21.7m vs. 13.3m, p=0.1) with a similar trend for mOS performing a Mantel-Byar test at the same time-point.

AFR ancestry was associated with a higher CHD risk after adjusting for age (HR 2.91, p = 0.03), but it only showed a trend in in the fully adjusted model (HR 2.46, p = 0.10).

Advanced‐stage patients also showed a trend for higher CEA levels and more tumors in the rectum (0.05 < P < 0.1).

Three of five responder candidate genes were significantly altered in responders versus nonresponders or showed a trend toward significantly altered expression ( P < 0.10) (see Table 3 ). 7.3.

The models were adjusted for variables that showed a trend for significant difference ( P < 0.1) in univariable analysis, including age, sex, hypertension, diabetes mellitus, heart failure (Killip classes II-IV), ST-segment elevation, history of PCI, low-density lipoprotein cholesterol (LDL-C), creatinine, pre-PCI Thrombolysis in Myocardial Infarction (TIMI) grade flow of 0, door-to-balloon (D2B) time, culprit lesion, thrombus aspiration, use of intra-aortic balloon pump (IABP), and use of glycoprotein IIb/IIIa (GP IIb/IIIa) inhibitors and aspirin.

Among the 30 CpG sites measured surrounding the Jag1 transcription start site (TSS) (+29 to −106), four were significantly hypomethylated while 12 showed a trend towards decreased DNA methylation (P < 0.1), with differences reaching 9% ( Figure 5d ).

Limbs with any non-closure also showed a trend toward less symptom improvement (“much better:” 50.0% vs 79.6%; P = .10) and less improvement in visual appearance (“much better:” 66.7% vs 81.6%; P = .083), although these differences did not reach statistical significance.

However, patients with RAS wild-type, right-sided mCRC who received bevacizumab in the first-line setting showed a trend toward longer OS than those who received cetuximab (HR 1.36; 95% CI 0.93–1.99; p = 0.10).

Lesions located in a dorsal or palmar/plantar location on the LM projection earned a lower average prize money per race ( p ≤ 0.05) than those in a central location, and showed a trend toward earning lower total prize money ( p ≤ 0.1) and number of places ( p ≤ 0.1).

Time × group analysis of the D2 test showed a trend ( p < 0.1) toward improved cognition.

At the same time, dapagliflozin administered in the absence of a high-glucose milieu showed a trend toward PM thickening ( p = 0.10), whereas increases in proinflammatory cytokines such as IL-6, TNF-α, and MCP-1, and anti-inflammatory cytokines such as IL-10 and IFN-γ were not statistically significant.

Pooled results showed a trend toward reduced neonatal hypoglycemia in the CGM group compared with the SMBG group (RR 0.85, 95% CI 0.70 to 1.03, P = 0.10, I2 = 0%, Figure 4A ).

In females, SPARC‐null mice showed a trend toward decreased expression of TIMP4 mRNA compared to WT mice ( P = .1, Figure 7I ).

Cognition as assessed by the EpiTrack tool showed a trend toward improvement, with mean (SD) scores of 27.7 (2.2) at baseline and 29.1 (2.1) at 8-month follow-up visit (mean change +1.30; P < .10).

In this cluster, children with ADHD with a smaller thalamic volume showed a greater reduction in the surface area ( r =0.60, df=23, p =0.001), while controls showed a trend towards a negative association with thalamic volume ( r =−0.34, df=22, p =0.1).

In addition, subjects walked with significantly greater step width variability (F (1,85) = 19.12, η 2 = 0.18, p <0.01) and showed a trend of walking with greater step time variability (F (1,85) = 2.81, p = 0.10) during POST than during PRE.

In addition, the total areas of GFP positive blood cell occlusions in the capillaries showed a trend (0.05< p <0.1) towards decreasing in the SCF+G-CSF-treated TgNotch3R90C mice ( p =0.06) ( Fig. 4C ).